Listen To The Lancet Gastroenterology & Hepatology
In conversation with... Arndt Vogel
- Autor: Vários
- Narrador: Vários
- Editor: Podcast
- Duración: 0:18:31
- Mas informaciones
Informações:
Sinopsis
Arndt Vogel (Toronto General Hospital) discusses the NALIRICC trial of nanoliposomal irinotecan added to fluorouracil plus leucovorin in patients with cholangiocarcinoma and gallbladder carcinoma previously treated with gemcitabine-based therapies.
